Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS365 in moderate to severe dry eye disease
NCT00679718Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jan 2000
- Primary completion
- Jul 2000
01
Overview
A Phase 2 trial of diquafosol in dry eye disease (DED), sponsored by Merck & Co.. Started Jan 2000; status: completed.
02
Drugs
diquafosol
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT00679718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00679718.